Mankind Pharma Limited (NSE:MANKIND)

India flag India · Delayed Price · Currency is INR
2,474.10
-27.90 (-1.12%)
Aug 28, 2025, 3:30 PM IST
-1.12%
Market Cap1.02T
Revenue (ttm)129.10B
Net Income (ttm)18.93B
Shares Out412.76M
EPS (ttm)46.42
PE Ratio53.30
Forward PE45.32
Dividend2.00 (0.08%)
Ex-Dividend DateAug 8, 2025
Volume233,207
Average Volume577,525
Open2,504.50
Previous Close2,502.00
Day's Range2,470.00 - 2,523.10
52-Week Range2,115.10 - 3,054.80
Beta0.35
RSI44.12
Earnings DateJul 31, 2025

About Mankind Pharma

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, respiratory diseases, etc. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, oral contraceptives, antacid powders, vitamin a... [Read more]

Sector Healthcare
Founded 1991
Employees 26,978
Stock Exchange National Stock Exchange of India
Ticker Symbol MANKIND
Full Company Profile

Financial Performance

In 2024, Mankind Pharma's revenue was 122.07 billion, an increase of 18.98% compared to the previous year's 102.60 billion. Earnings were 19.91 billion, an increase of 4.08%.

Financial Statements

News

There is no news available yet.